108 related articles for article (PubMed ID: 34404131)
1. [Effect of axillary lymph node status on prognosis of different types of invasive breast cancer].
He YJ; Fan ZQ; Li JF; Wang TF; Xie YT; Wang LZ; Ouyang T
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2382-2386. PubMed ID: 34404131
[No Abstract] [Full Text] [Related]
2. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.
Lim ST; Choi JE; Kim SJ; Kim HA; Kim JY; Park HK; Suh YJ
Breast Cancer Res Treat; 2016 Apr; 156(3):473-483. PubMed ID: 27041335
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
Liu ZF; Chen C; Yao XL; Sun SR
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla.
Bi Z; Liu J; Chen P; Liu Y; Zhao T; Wang C; Zhang Z; Sun X; Qiu P; Cong B; Song X; Wang Y
Breast Cancer; 2019 May; 26(3):373-377. PubMed ID: 30666563
[TBL] [Abstract][Full Text] [Related]
5. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
6. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
7. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
8. Better predictive value of axillary lymph node (ALN) status after systemic therapy for operable HER2-overexpressing breast cancer: A single-institution retrospective study.
Zhang Y; Mo M; Li JW; Zhou Y; Wu J; Yu KD; Shen ZZ; Shao ZM; Liu GY
Eur J Surg Oncol; 2016 Aug; 42(8):1146-52. PubMed ID: 27365197
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
van Nijnatten TJ; Simons JM; Moossdorff M; de Munck L; Lobbes MB; van der Pol CC; Koppert LB; Luiten EJ; Smidt ML
Breast Cancer Res Treat; 2017 May; 163(1):159-166. PubMed ID: 28213782
[TBL] [Abstract][Full Text] [Related]
10. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
[TBL] [Abstract][Full Text] [Related]
12. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
[No Abstract] [Full Text] [Related]
13. [Analysis of factors influencing the axillary lymph node metastasis and breast cancer-specific survival in patients with T1 breast cancer].
Jiao DC; Qiao JH; Zhu JJ; Wang LN; Ma YZ; Lu ZD; Liu ZZ
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3258-3262. PubMed ID: 30392292
[No Abstract] [Full Text] [Related]
14. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Axillary Ultrasound versus Sentinel Lymph Node Biopsy in Patients with Early Breast Cancer.
Rukanskienė D; Veikutis V; Jonaitienė E; Basevičiūtė M; Kunigiškis D; Paukštaitienė R; Čepulienė D; Poškienė L; Boguševičius A
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183080
[No Abstract] [Full Text] [Related]
16. The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society.
Kim HS; Yoo TK; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Apr; 180(2):461-470. PubMed ID: 32020434
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
[TBL] [Abstract][Full Text] [Related]
18. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
Mittra I; Redkar AA; Badwe RA
J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
[TBL] [Abstract][Full Text] [Related]
20. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
Mougalian SS; Hernandez M; Lei X; Lynch S; Kuerer HM; Symmans WF; Theriault RL; Fornage BD; Hsu L; Buchholz TA; Sahin AA; Hunt KK; Yang WT; Hortobagyi GN; Valero V
JAMA Oncol; 2016 Apr; 2(4):508-16. PubMed ID: 26720612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
